XRAYVISION Trademark

Trademark Overview

On Friday, September 9, 2022, a trademark application was filed for XRAYVISION with the United States Patent and Trademark Office. The USPTO has given the XRAYVISION trademark a serial number of 79351724. The federal status of this trademark filing is REGISTERED as of Tuesday, January 2, 2024. This trademark is owned by Merck KGaA. The XRAYVISION trademark is filed in the Education & Entertainment Services category with the following description:

Publication of the results of clinical trials for pharmaceutical preparations in the form of brochures, articles and newsletters
xrayvision

General Information

Serial Number79351724
Word MarkXRAYVISION
Filing DateFriday, September 9, 2022
Status700 - REGISTERED
Status DateTuesday, January 2, 2024
Registration Number7256776
Registration DateTuesday, January 2, 2024
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 17, 2023

Trademark Statements

Goods and ServicesPublication of the results of clinical trials for pharmaceutical preparations in the form of brochures, articles and newsletters
Description of MarkThe mark consists of the stylized wording "XRAYVISION" with the letter "X" consisting of one bold diagonal line and three thinner diagonal lines crossing in the opposite direction.
Pseudo MarkX RAY VISION

Classification Information

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateFriday, October 7, 2022
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMerck KGaA
Party Type30 - Original Registrant
Legal Entity Type31 - NOT AVAILABLE
AddressDE
Party NameMerck KGaA
Party Type20 - Owner at Publication
Legal Entity Type31 - NOT AVAILABLE
AddressDE
Party NameMerck KGaA
Party Type10 - Original Applicant
Legal Entity Type31 - NOT AVAILABLE
AddressDE

Trademark Events

Event DateEvent Description
Thursday, April 4, 2024FINAL DISPOSITION NOTICE SENT TO IB
Thursday, April 4, 2024FINAL DISPOSITION PROCESSED
Tuesday, April 2, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 2, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 2, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, October 17, 2023NOTIFICATION PROCESSED BY IB
Tuesday, October 17, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 17, 2023PUBLISHED FOR OPPOSITION
Wednesday, September 27, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 27, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 27, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 14, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 24, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 24, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 24, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 2, 2023REFUSAL PROCESSED BY IB
Thursday, April 13, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, April 13, 2023REFUSAL PROCESSED BY MPU
Thursday, February 23, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, February 22, 2023NON-FINAL ACTION WRITTEN
Friday, February 10, 2023ASSIGNED TO EXAMINER
Tuesday, October 11, 2022APPLICATION FILING RECEIPT MAILED
Friday, October 7, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 6, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

xrayvision form brochures articles newsletters preparations pharmaceutical results clinical trials publication